Teva's AJOVY® Receives EU Approval Offering Patients the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Prophylaxis of Migraine in Adults | Business Wire
dough on Twitter: "@JohnCFierce $ACAD potential interested parties in $ACAD $BIIB $TEVA $AGN $PFE. IMHO I think it's $LLY https://t.co/QM6XZkoGwJ" / Twitter
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Refreshing the biologic pipeline 2020 | Nature Biotechnology
Teva's Key Drugs in Its Specialty Products Pipeline
Teva drug shows promise in movement disorder - PMLiVE
EX-99.1
Teva leans on Ajovy and Austedo as revenues sink
Berkovish Branding & Web Design Studio.
TEVA | Market Realist
A Look at Teva's Generic Drugs Research Pipeline
Teva Pharmaceuticals Near 20-Year Lows (NYSE:TEVA) | Seeking Alpha
Teva's (TEVA) NDA for Schizophrenia Drug Gets FDA Acceptance
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
Sosei see Teva pipeline cull as an opportunity | pharmaphorum
Teva Pharmaceutical Industries Ltd (TEVA) - Product Pipeline Analysis, 2021 Update
Teva, chasing Amgen's Aimovig, scores much-needed FDA approval for migraine drug Ajovy | Fierce Pharma
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfate 117 mcg) Inhalation Powder | Business Wire
EX-99.1
Generic Drugs in the Pipeline: 2017 Update
Teva: We Believe In Biosimilars, But Pipeline And Timing Come First :: Generics Bulletin
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
